Economic Assessment of a Predictive Technology for the Early Detection of Oral Cancer

Health economic evaluation provides information about the value for money of new healthcare technologies, and is increasingly used to guide the allocation of scarce resources based on maximizing health gain. The molecular diagnostics company, PDI, has developed a technology to improve the identification of patients at high risk for oral cancers for early intervention, and distinguish abnormal cell growth that will not become malignant, compared to the current gold standard alone.

Development of thyroglobulin specific aptamers for detection of thyroid carcinoma in the presence of thyroglobulin specific auto-antibodies

Thyroid cancer is the most frequent endocrine cancer. Over 90% of thyroid cancers are of the follicular or papillary type termed differentiated thyroid carcinoma (DTC). Thyroglobulin (Tg) serum measurement is an integral part of the follow up and management of DTC patients. Serum Tg levels are conventionally measured using either an immunometric assay (IMA) or radioimmunometric assay (RIA). Both methods rely on the use of labeled exogenous antibodies.

Economic Assessment Of A Predictive Technology For The Early Detection Of Oral Cancer

Health economic evaluation provides information about the value for money of new healthcare technologies, and is increasingly used to guide the allocation of scarce resources based on maximizing health gain. The molecular diagnostics company, PDI, has developed a technology to improve the identification of patients at high risk for oral cancers for early intervention, and distinguish abnormal cell growth that will not become malignant, compared to the current gold standard alone.